ロード中...
Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers
Lynch syndrome (LS) individuals are predisposed to a variety of cancers, most commonly colorectal, uterine, urinary tract, ovarian, small bowel, stomach and biliary tract cancers. The risk of extracolonic manifestations appears to be highest in MSH2 mutations carriers. We present a carrier case with...
保存先:
主要な著者: | , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BioMed Central
2012
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3275504/ https://ncbi.nlm.nih.gov/pubmed/22234272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1897-4287-10-1 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|